entity

TREM2, APOE, MAPT

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TREM2, APOE, MAPT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

0Connections
1Hypotheses
0Analyses
0Outgoing
0Incoming

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.456 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (7)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Female sex is linked to a stronger association between sTREM2 and CSF p-tau in A [PMID:39794447] Biel D, Suárez-Calvet M, Dewenter A, Ste EMBO Mol Med 2025 0
Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treat [PMID:38247923] Nystuen KL, McNamee SM, Akula M, Holton Bioengineering (Basel) 2024 0
Gene replacement-Alzheimer's disease (GR-AD): Modeling the genetics of human dem [PMID:38343132] Benzow K, Karanjeet K, Oblak AL, Carter Alzheimers Dement 2024 0
Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological an [PMID:36002854] Haure-Mirande JV, Audrain M, Ehrlich ME, Mol Neurodegener 2022 0
Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent [PMID:33314529] Audrain M, Haure-Mirande JV, Mleczko J, Alzheimers Dement 2021 0
Systematic review of genetic association studies in people with Lewy body dement [PMID:31898332] Sanghvi H, Singh R, Morrin H, Rajkumar A Int J Geriatr Psychiatry 2020 0
Practical considerations for choosing a mouse model of Alzheimer's disease. [PMID:29273078] Jankowsky JL, Zheng H Mol Neurodegener 2017 0